Literature DB >> 30235006

Reply to Zuckerman and Saiman: Use of Masks in Patients with Cystic Fibrosis.

Michelle E Wood1,2,3, Rebecca E Stockwell2,3, Scott C Bell1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30235006      PMCID： PMC7212799          DOI： 10.1164/rccm.201808-1476LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Counterpoint: does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? No.

Authors:  Steven L Shepherd; Eric J Goodrich; Julie Desch; Paul M Quinton
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

2.  Point: does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? Yes.

Authors:  Manu Jain; Lisa M Saiman; Kathy Sabadosa; John J LiPuma
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

3.  Air contamination with bacteria in cystic fibrosis clinics: implications for prevention strategies.

Authors:  Jonathan B Zuckerman; Sarah A Clock; B Stephen Prato; James J McDevitt; Juyan Julia Zhou; Laurie W Leclair; F Lee Lucas; Lisa Saiman
Journal:  Am J Respir Crit Care Med       Date:  2015-03-01       Impact factor: 21.405

4.  Face Masks Reduce the Release of Pseudomonas aeruginosa Cough Aerosols When Worn for Clinically Relevant Periods.

Authors:  Rebecca E Stockwell; Michelle E Wood; Congrong He; Laura J Sherrard; Emma L Ballard; Timothy J Kidd; Graham R Johnson; Luke D Knibbs; Lidia Morawska; Scott C Bell
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 21.405

5.  Infection prevention and control guideline for cystic fibrosis: 2013 update.

Authors:  Lisa Saiman; Jane D Siegel; John J LiPuma; Rebekah F Brown; Elizabeth A Bryson; Mary Jo Chambers; Veronica S Downer; Jill Fliege; Leslie A Hazle; Manu Jain; Bruce C Marshall; Catherine O'Malley; Suzanne R Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A Robinson; Kathryn A Sabadosa; H Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-01       Impact factor: 3.254

6.  Face Masks and Cough Etiquette Reduce the Cough Aerosol Concentration of Pseudomonas aeruginosa in People with Cystic Fibrosis.

Authors:  Michelle E Wood; Rebecca E Stockwell; Graham R Johnson; Kay A Ramsay; Laura J Sherrard; Nassib Jabbour; Emma Ballard; Peter O'Rourke; Timothy J Kidd; Claire E Wainwright; Luke D Knibbs; Peter D Sly; Lidia Morawska; Scott C Bell
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

7.  Room ventilation and the risk of airborne infection transmission in 3 health care settings within a large teaching hospital.

Authors:  Luke D Knibbs; Lidia Morawska; Scott C Bell; Piotr Grzybowski
Journal:  Am J Infect Control       Date:  2011-06-12       Impact factor: 2.918

8.  Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.

Authors:  C E Wainwright; M W France; P O'Rourke; S Anuj; T J Kidd; M D Nissen; T P Sloots; C Coulter; Z Ristovski; M Hargreaves; B R Rose; C Harbour; S C Bell; K P Fennelly
Journal:  Thorax       Date:  2009-07-01       Impact factor: 9.139

9.  Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.

Authors:  Luke D Knibbs; Graham R Johnson; Timothy J Kidd; Joyce Cheney; Keith Grimwood; Jacqueline A Kattenbelt; Peter K O'Rourke; Kay A Ramsay; Peter D Sly; Claire E Wainwright; Michelle E Wood; Lidia Morawska; Scott C Bell
Journal:  Thorax       Date:  2014-04-17       Impact factor: 9.139

10.  A Novel Method and Its Application to Measuring Pathogen Decay in Bioaerosols from Patients with Respiratory Disease.

Authors:  Graham R Johnson; Luke D Knibbs; Timothy J Kidd; Claire E Wainwright; Michelle E Wood; Kay A Ramsay; Scott C Bell; Lidia Morawska
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.